Camp4 Therapeutics (CAMP) Treasury Shares (2023 - 2025)

Name: Camp4 Therapeutics (CAMP) Treasury Shares (2023 - 2025) | Business Quant
Creator: Business Quant

Camp4 Therapeutics recorded quarterly Treasury Shares of $4277.0 in Q1 2025, down 73.17% quarter-over-quarter from $15943.0 in Q4 2024.

Camp4 Therapeutics' Treasury Shares history runs 3 years deep, the most recent figure standing at $4277.0 for Q1 2025.

In Q1 2025, Treasury Shares changed N/A year-over-year to $4277.0; the TTM figure through Mar 2025 stood at $4277.0 (changed N/A YoY), while the FY2024 annual figure was $15943.0, down 78.53% from the prior year.
Treasury Shares came in at $4277.0 for Q1 2025 at Camp4 Therapeutics, down from $15943.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $74243.0 in Q4 2023 to a low of $4277.0 in Q1 2025.
A 3-year average of $31267.5 and a median of $23275.0 in 2024 frame the typical range for Treasury Shares.
On a YoY basis, Treasury Shares climbed as much as 78.53% in 2024 and fell as far as 78.53% in 2024.
Camp4 Therapeutics' Treasury Shares stood at $74243.0 in 2023, then sank by 78.53% to $15943.0 in 2024, then slumped by 73.17% to $4277.0 in 2025.
According to Business Quant data, Treasury Shares over the past three periods registered $4277.0, $15943.0, and $30607.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	265,401.92
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	700,000.00
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	34.70 Mn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Camp4 Therapeutics	245.89 Mn	245.89 Mn	-	-

Download Data 🔒